Cargando…

CD14(+)HLA-DR(low/−) expression: A novel prognostic factor in chronic lymphocytic leukemia

Currently, no prognostic factors exist for determining the host immune status of chronic lymphocytic leukemia (CLL) patients. Therefore, the present report analyzed cluster of differentiation 14 (CD14)(+) human leukocyte antigen (HLA)-DR(low/−) myeloid-derived suppressor cells (MDSC) from 49 CLL pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, JINLIN, ZHOU, YONGLIE, HUANG, QIANG, QIU, LIANNV
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314977/ https://www.ncbi.nlm.nih.gov/pubmed/25663875 http://dx.doi.org/10.3892/ol.2014.2808

Ejemplares similares

Functionally impaired follicular helper T cells induce regulatory B cells and CD14(+) human leukocyte antigen‐DR (−) cell differentiation in non‐small cell lung cancer
por: Qiu, Liannv, et al.
Publicado: (2018)

ZGDHu-1 promotes apoptosis of mantle cell lymphoma cells
por: Qiu, Liannv, et al.
Publicado: (2016)

ZGDHu-1 for cancer therapy
por: Liu, Jinlin, et al.
Publicado: (2017)

Higher Frequency of CD4(+)CXCR5(+)ICOS(+)PD1(+) T Follicular Helper Cells in Patients With Infectious Mononucleosis
por: Liu, Jinlin, et al.
Publicado: (2015)

The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens
Publicado: (1988)

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4(+) T Lymphocytes
por: Chaux, Pascal, et al.
Publicado: (1999)

Decreased levels of regulatory B cells in patients with acute pancreatitis: association with the severity of the disease
por: Qiu, Liannv, et al.
Publicado: (2018)

DC-HIL(+) CD14(+) HLA-DR(no/low) Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma
por: Turrentine, Jake, et al.
Publicado: (2014)

Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia
por: Aref, Salah, et al.
Publicado: (2023)

Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients
por: Xue, GuoHui, et al.
Publicado: (2021)

CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018)

IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/−) monocytes in B-cell non-Hodgkin lymphoma
por: Xiu, B, et al.
Publicado: (2015)

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)

Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021)

The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019)

Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation
por: Asmussen, Alexander, et al.
Publicado: (2021)

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

Level of CD8 T Lymphocytes Activation in HIV-Infected Pregnant Women: In the Context of CD38 and HLA-DR Activation Markers
por: Musyoki, Stanslaus, et al.
Publicado: (2014)

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
por: Dietz, Allan B, et al.
Publicado: (2013)

CD73 Promotes Chronic Lymphocytic Leukemia
por: Allard, David, et al.
Publicado: (2022)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

HLA-DR polymorphism affects the interaction with CD4
Publicado: (1995)

Prognostic Role of Lymphocyte/Monocyte Ratio in Chronic Lymphocytic Leukemia
por: Yokus, Osman, et al.
Publicado: (2020)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Circulating CD14(+) HLA‐DR (‐/low) myeloid‐derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft‐versus‐host disease
por: Yin, Jin, et al.
Publicado: (2016)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation
por: Di Bernardo, Maria Chiara, et al.
Publicado: (2012)

Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia
por: Miao, Yi, et al.
Publicado: (2016)

HIV DNA positively correlates with HLA-DR+CD8+ T lymphocytes over 8-year suppressive antiretroviral therapy
por: Zhu, Tianyuan, et al.
Publicado: (2023)

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia
por: Gutjahr, Julia Christine, et al.
Publicado: (2015)

Novel agents for chronic lymphocytic leukemia
por: Wu, Mei, et al.
Publicado: (2013)

Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in ovarian cancer patients
por: Wu, Liangliang, et al.
Publicado: (2017)

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia
por: Evans, Sarah S., et al.
Publicado: (2015)

Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses
por: Laborde, Rebecca R., et al.
Publicado: (2014)

Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.
por: Taylor, G. M., et al.
Publicado: (1984)

Cutaneous plaque in adult T cell leukemia/lymphoma: A case report
por: Lei, Chen Shuang, et al.
Publicado: (2020)

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia
por: Griffen, Ti’ara L., et al.
Publicado: (2023)

CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance
por: D’Arena, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q18kpn0f0ndmtj1aihqotvodc9